Skip to main content

Peer Review reports

From: Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Original Submission
6 Aug 2008 Submitted Original manuscript
7 Aug 2008 Author responded Author comments - Erik Skof
Resubmission - Version 2
7 Aug 2008 Submitted Manuscript version 2
29 Aug 2008 Author responded Author comments - Erik Skof
Resubmission - Version 3
29 Aug 2008 Submitted Manuscript version 3
19 Sep 2008 Reviewed Reviewer Report - John Souglakos
19 Sep 2008 Reviewed Reviewer Report - Jorge Aparicio
21 Nov 2008 Author responded Author comments - Erik Skof
Resubmission - Version 4
21 Nov 2008 Submitted Manuscript version 4
7 Dec 2008 Reviewed Reviewer Report - Jorge Aparicio
6 Mar 2009 Reviewed Reviewer Report - John Souglakos
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
22 Apr 2009 Editorially accepted
22 Apr 2009 Article published 10.1186/1471-2407-9-120

You can find further information about peer review here.

Back to article page